Aspire Biopharma Holdings, Inc.
ASBPWNasdaq
$0.02
↓ -11.5%Jul 17 close · end-of-day
Price
1Y↓ -65.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$2,773.32
Enterprise Value
-$5.9M
P/E
—
P/S
—
P/B
0.0
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$11.8M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-304.1%
ROIC
—
Debt / Equity
—
Net Cash
$5.9M
Return 1Y
-65.3%
Earnings
ASBPW Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$28,353.00—
Diluted EPS-$20.57↓ -95.9%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | — | — | — | $6,202.00 |
| Gross profit | — | — | — | -$116.00 |
| Operating income | — | — | -$1.2M | -$19.4M |
| Net income | $3.3M | $4.5M | -$1.3M | -$24.5M |
| Diluted EPS | — | — | -$1.90 | -$16.38 |
| Operating cash flow | -$1.4M | -$653,107.00 | -$265,186.00 | -$4.9M |
| Free cash flow | — | — | — | — |
| Gross margin | — | — | — | -1.9% |
| Operating margin | — | — | — | -312016.9% |
| Net margin | — | — | — | -394725.1% |
| Line item | Q3 '24 | Q3 '24 | Q3 '24 | Q1 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $1,941.00 | — | $28,353.00 |
| Gross profit | — | — | — | — | — | $884.00 | — | $5,750.00 |
| Operating income | — | -$215,256.00 | — | -$15.6M | — | -$1.1M | — | -$1.6M |
| Net income | -$96,923.00 | -$216,269.00 | -$765,710.00 | -$15.9M | -$2.0M | -$1.9M | -$4.7M | -$3.2M |
| Diluted EPS | — | -$0.01 | — | -$504.88 | — | -$0.04 | — | -$20.57 |
| Operating cash flow | -$56,244.00 | -$495,540.00 | $479,569.00 | -$1.8M | -$1.1M | -$1.1M | -$927,841.00 | -$3.0M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | 45.5% | — | 20.3% |
| Operating margin | — | — | — | — | — | -59015.8% | — | -5806.0% |
| Net margin | — | — | — | — | — | -95337.1% | — | -11367.0% |
Company news
Coming soonHeadlines for ASBPW will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.